Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Resorcinol is a 1,3-isomer (or meta-isomer) of benzenediol with the formula C6H4(OH)2. It is used as an antiseptic and disinfectant in topical pharmaceutical products in the treatment of skin disorders... It exerts a keratolytic activity.
- Mechanism
- Curator reviewed · 3 references
Data regarding the specific mechanisms of action of resorcinol does not appear to be readily accessible in the literature. Nevertheless, the effectiveness of the agent in treating various topical, dermatological conditions by eliciting antibacterial and keratolytic actions appears to stem from resorcinol's propensity for protein precipitation. In particular, it appears that resorcinol indicated for treating acne, dermatitis, or eczema in various skin care topical applications and peels revolves around the compound's ability to precipitate cutaneous proteins from the treated skin.
- Primary indication
- Contemporary therapeutic uses for resorcinol primarily revolve around the use of the phenol derivative as an active ingredient in topical antiseptics or as topical antibacterial skin treatment products for conditions like acne, seborrheic dermatitis, eczema,...Curator reviewed · 1 structured indication
- Formula / weight
- C6H6O2 · 110.1106 g/mol (avg)
- First approval
- Canada, 1999
- Also known as
- 1,3-Benzenediol · 1,3-Dihydroxybenzene · m-Hydroquinone · m-hydroxyphenol
- Code names
- C.I.-76505 · FEMA NO. 3589 · NSC-1571
- Brand names
- Acnomel
- Resinol
- Rezamid
- Vagisil Original Formula
Resolves to
GHMLBKRAJCXXBS-UHFFFAOYSA-NSMILESOC1=CC(O)=CC=C1What you can answer from here — as of September 23, 2026
Which drugs share a target with Resorcinol, and which of those have an active Phase 3 trial?